CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations
Cem Kuscu1, Mahmut Parlak1, Turan Tufan1
1Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
CRISPR-STOP uses CRISPR base editors to efficiently knock out genes by creating stop codons. This method is less damaging than wild-type Cas9 for gene knockout and functional screening applications.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- CRISPR-Cas9 gene editing can cause unintended DNA damage, particularly in high-copy-number genomic regions.
- Efficient and precise gene knockout methods are crucial for functional genomics and disease research.
Purpose of the Study:
- To develop a gene knockout strategy using CRISPR base editors that minimizes deleterious DNA damage.
- To evaluate the efficiency and safety of CRISPR-STOP compared to wild-type Cas9 for gene knockout.
Main Methods:
- Utilized CRISPR base editors to introduce single-nucleotide changes, creating premature stop codons for gene knockout.
- Applied the CRISPR-STOP method to target approximately 17,000 human genes.
- Performed CRISPR-STOP-mediated targeted screening and compared its efficiency to wild-type Cas9.
Main Results:
- Demonstrated that CRISPR-STOP is an efficient method for gene knockout.
- Showed that CRISPR-STOP induces less deleterious DNA damage compared to wild-type Cas9.
- Achieved screening efficiency comparable to wild-type Cas9 using the CRISPR-STOP approach.
Conclusions:
- CRISPR-STOP offers an efficient and safer alternative to wild-type Cas9 for gene knockout studies.
- The method is suitable for genome-wide functional screening due to its comparable efficiency and reduced DNA damage.
- Enables targeted gene inactivation through precise nucleotide modification.
More Related Videos
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
